CLINICAL_TRIALS
trial_result
· 2009-08-26
Clinical Trial Update: A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus [Phase 3]
Summary
Phase 3 trial evaluating inhaled insulin for glucose control in type 2 diabetes was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Diabetes Mellitus Type 2 | Phase 3 | Status: TERMINATED | Results posted: 2009-08-26